MedPath

Improvement of Cerebrovascular Autoregulation in Patients With Septic Shock Due to Cytokine Elimination

Not Applicable
Conditions
Septic Shock
Interventions
Device: Cytokine absorption
Registration Number
NCT04259567
Lead Sponsor
Johannes Gutenberg University Mainz
Brief Summary

The trial investigates the effect of cytokine elimination in patients with septic schock and acute renal failure with need for renal replacement therapy on the integrity of cerebrovascular autoregulation. Patients with inclusion criteria were randomly assign in either use of CytoSorb filter integrated in renal replacement therapy versus non additional filter an renal replacement therapy alone. Cerebrovascular autoregulation will be measured with transcranial Doppler ultrasound and correlation with arterial blood pressure.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • septic shock
  • acute renal failure with need for renal replacement therapy
Exclusion Criteria
  • pregnancy
  • nursing
  • impossibility to do transcranial Doppler ultrasound

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FilterCytokine absorptionPatients with CytoSorb absorber
Primary Outcome Measures
NameTimeMethod
Differences in the index of cerebrovascular autoregulation (Mx) between both groupsdays 1 to 4 after diagnosis of septic shock

Integrity of the cerebrovascular autoregulation will be measured using the index of cerebrovascular autoregulation Mx (moving correlation index). Outcome is the difference of the mean Mx between both groups and, therefore, the difference of integrity of the cerbrovascular autoregulation. A difference of 0.2 in Mx was set as clinically relevant.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Medical Center of the Johannes Gutenberg-Univerity

🇩🇪

Mainz, Germany

© Copyright 2025. All Rights Reserved by MedPath